nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP11A1—Dexamethasone—multiple sclerosis	0.234	0.28	CbGbCtD
Aminoglutethimide—CYP19A1—Betamethasone—multiple sclerosis	0.188	0.224	CbGbCtD
Aminoglutethimide—CYP19A1—Dexamethasone—multiple sclerosis	0.109	0.13	CbGbCtD
Aminoglutethimide—CYP3A4—Fingolimod—multiple sclerosis	0.0567	0.0678	CbGbCtD
Aminoglutethimide—CYP2C19—Prednisone—multiple sclerosis	0.0458	0.0548	CbGbCtD
Aminoglutethimide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0366	0.0437	CbGbCtD
Aminoglutethimide—CYP2C19—Dexamethasone—multiple sclerosis	0.0286	0.0342	CbGbCtD
Aminoglutethimide—CYP3A4—Triamcinolone—multiple sclerosis	0.0277	0.0331	CbGbCtD
Aminoglutethimide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0267	0.0319	CbGbCtD
Aminoglutethimide—CYP3A4—Betamethasone—multiple sclerosis	0.0238	0.0284	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisolone—multiple sclerosis	0.0235	0.028	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisone—multiple sclerosis	0.0221	0.0265	CbGbCtD
Aminoglutethimide—CYP3A4—Dexamethasone—multiple sclerosis	0.0138	0.0165	CbGbCtD
Aminoglutethimide—Adrenal insufficiency—Prednisone—multiple sclerosis	0.00438	0.0443	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00303	0.0468	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00303	0.0468	CbGpPWpGaD
Aminoglutethimide—Alveolitis allergic—Methotrexate—multiple sclerosis	0.00294	0.0297	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Azathioprine—multiple sclerosis	0.00247	0.025	CcSEcCtD
Aminoglutethimide—Hirsutism—Prednisolone—multiple sclerosis	0.00217	0.022	CcSEcCtD
Aminoglutethimide—Haematocrit decreased—Methotrexate—multiple sclerosis	0.00206	0.0208	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00201	0.031	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00201	0.031	CbGpPWpGaD
Aminoglutethimide—Hirsutism—Triamcinolone—multiple sclerosis	0.002	0.0202	CcSEcCtD
Aminoglutethimide—Hirsutism—Methylprednisolone—multiple sclerosis	0.00199	0.0202	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Cladribine—multiple sclerosis	0.00188	0.0191	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00188	0.029	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00188	0.029	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00186	0.0287	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00186	0.0287	CbGpPWpGaD
Aminoglutethimide—Hirsutism—Betamethasone—multiple sclerosis	0.00181	0.0184	CcSEcCtD
Aminoglutethimide—Hirsutism—Dexamethasone—multiple sclerosis	0.00181	0.0184	CcSEcCtD
Aminoglutethimide—Leukopenia—Fingolimod—multiple sclerosis	0.00162	0.0164	CcSEcCtD
Aminoglutethimide—Hirsutism—Prednisone—multiple sclerosis	0.00158	0.016	CcSEcCtD
Aminoglutethimide—CYP11A1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.00156	0.024	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00152	0.0235	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00152	0.0235	CbGpPWpGaD
Aminoglutethimide—Hypothyroidism—Prednisone—multiple sclerosis	0.00143	0.0145	CcSEcCtD
Aminoglutethimide—Pancytopenia—Cladribine—multiple sclerosis	0.0014	0.0141	CcSEcCtD
Aminoglutethimide—Hypotension—Fingolimod—multiple sclerosis	0.00138	0.0139	CcSEcCtD
Aminoglutethimide—Neutropenia—Cladribine—multiple sclerosis	0.00137	0.0139	CcSEcCtD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00125	0.0192	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00125	0.0192	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00123	0.019	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00123	0.019	CbGpPWpGaD
Aminoglutethimide—Pancytopenia—Azathioprine—multiple sclerosis	0.00113	0.0115	CcSEcCtD
Aminoglutethimide—Pruritus—Fingolimod—multiple sclerosis	0.00104	0.0106	CcSEcCtD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00101	0.0156	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00101	0.0156	CbGpPWpGaD
Aminoglutethimide—Agranulocytosis—Azathioprine—multiple sclerosis	0.000994	0.0101	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Methotrexate—multiple sclerosis	0.000993	0.0101	CcSEcCtD
Aminoglutethimide—Dizziness—Fingolimod—multiple sclerosis	0.000975	0.00986	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.000964	0.0149	CbGpPWpGaD
Aminoglutethimide—Anaemia—Cladribine—multiple sclerosis	0.000946	0.00958	CcSEcCtD
Aminoglutethimide—Headache—Fingolimod—multiple sclerosis	0.000923	0.00935	CcSEcCtD
Aminoglutethimide—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000917	0.00928	CcSEcCtD
Aminoglutethimide—CYP11A1—Endogenous sterols—POMC—multiple sclerosis	0.000911	0.0141	CbGpPWpGaD
Aminoglutethimide—Neutropenia—Mitoxantrone—multiple sclerosis	0.000903	0.00914	CcSEcCtD
Aminoglutethimide—Myalgia—Cladribine—multiple sclerosis	0.000871	0.00882	CcSEcCtD
Aminoglutethimide—Drowsiness—Mitoxantrone—multiple sclerosis	0.000861	0.00871	CcSEcCtD
Aminoglutethimide—Tachycardia—Cladribine—multiple sclerosis	0.000815	0.00825	CcSEcCtD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP27B1—multiple sclerosis	0.00081	0.0125	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP24A1—multiple sclerosis	0.00081	0.0125	CbGpPWpGaD
Aminoglutethimide—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000803	0.00813	CcSEcCtD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000799	0.0123	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000799	0.0123	CbGpPWpGaD
Aminoglutethimide—Anorexia—Cladribine—multiple sclerosis	0.000796	0.00806	CcSEcCtD
Aminoglutethimide—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.000787	0.0121	CbGpPWpGaD
Aminoglutethimide—Hypotension—Cladribine—multiple sclerosis	0.000781	0.0079	CcSEcCtD
Aminoglutethimide—Anaemia—Azathioprine—multiple sclerosis	0.000769	0.00779	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000761	0.0077	CcSEcCtD
Aminoglutethimide—Leukopenia—Azathioprine—multiple sclerosis	0.000745	0.00754	CcSEcCtD
Aminoglutethimide—Somnolence—Cladribine—multiple sclerosis	0.000743	0.00752	CcSEcCtD
Aminoglutethimide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000742	0.0115	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000742	0.0115	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Cladribine—multiple sclerosis	0.000726	0.00735	CcSEcCtD
Aminoglutethimide—Myalgia—Azathioprine—multiple sclerosis	0.000709	0.00717	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000682	0.0105	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000674	0.0104	CbGpPWpGaD
Aminoglutethimide—Urticaria—Cladribine—multiple sclerosis	0.000664	0.00672	CcSEcCtD
Aminoglutethimide—Body temperature increased—Cladribine—multiple sclerosis	0.00066	0.00668	CcSEcCtD
Aminoglutethimide—Hypotension—Azathioprine—multiple sclerosis	0.000635	0.00642	CcSEcCtD
Aminoglutethimide—Anaemia—Mitoxantrone—multiple sclerosis	0.000622	0.00629	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000619	0.00626	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Cladribine—multiple sclerosis	0.000615	0.00623	CcSEcCtD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000605	0.00934	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000605	0.00934	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.000603	0.00932	CbGpPWpGaD
Aminoglutethimide—Leukopenia—Mitoxantrone—multiple sclerosis	0.000602	0.0061	CcSEcCtD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000597	0.00921	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000597	0.00921	CbGpPWpGaD
Aminoglutethimide—Pruritus—Cladribine—multiple sclerosis	0.000591	0.00598	CcSEcCtD
Aminoglutethimide—Myalgia—Mitoxantrone—multiple sclerosis	0.000573	0.0058	CcSEcCtD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000573	0.00884	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000573	0.00884	CbGpPWpGaD
Aminoglutethimide—Dizziness—Cladribine—multiple sclerosis	0.000552	0.00559	CcSEcCtD
Aminoglutethimide—Neutropenia—Prednisone—multiple sclerosis	0.000538	0.00545	CcSEcCtD
Aminoglutethimide—Body temperature increased—Azathioprine—multiple sclerosis	0.000537	0.00544	CcSEcCtD
Aminoglutethimide—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000536	0.00828	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000536	0.00828	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Mitoxantrone—multiple sclerosis	0.000536	0.00542	CcSEcCtD
Aminoglutethimide—Vomiting—Cladribine—multiple sclerosis	0.000531	0.00538	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000529	0.00817	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000529	0.00817	CbGpPWpGaD
Aminoglutethimide—Rash—Cladribine—multiple sclerosis	0.000527	0.00533	CcSEcCtD
Aminoglutethimide—Dermatitis—Cladribine—multiple sclerosis	0.000526	0.00533	CcSEcCtD
Aminoglutethimide—Anorexia—Mitoxantrone—multiple sclerosis	0.000523	0.0053	CcSEcCtD
Aminoglutethimide—Headache—Cladribine—multiple sclerosis	0.000523	0.0053	CcSEcCtD
Aminoglutethimide—Hypotension—Mitoxantrone—multiple sclerosis	0.000513	0.00519	CcSEcCtD
Aminoglutethimide—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000507	0.00783	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000506	0.00782	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Azathioprine—multiple sclerosis	0.0005	0.00507	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.0005	0.00506	CcSEcCtD
Aminoglutethimide—Nausea—Cladribine—multiple sclerosis	0.000496	0.00502	CcSEcCtD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00049	0.00757	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00049	0.00757	CbGpPWpGaD
Aminoglutethimide—Somnolence—Mitoxantrone—multiple sclerosis	0.000488	0.00494	CcSEcCtD
Aminoglutethimide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000477	0.00483	CcSEcCtD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000471	0.00727	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000471	0.00727	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000465	0.00718	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000465	0.00718	CbGpPWpGaD
Aminoglutethimide—Pancytopenia—Methotrexate—multiple sclerosis	0.000457	0.00462	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000452	0.00698	CbGpPWpGaD
Aminoglutethimide—Neutropenia—Methotrexate—multiple sclerosis	0.00045	0.00455	CcSEcCtD
Aminoglutethimide—Dizziness—Azathioprine—multiple sclerosis	0.000449	0.00455	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisolone—multiple sclerosis	0.00044	0.00445	CcSEcCtD
Aminoglutethimide—Urticaria—Mitoxantrone—multiple sclerosis	0.000436	0.00442	CcSEcCtD
Aminoglutethimide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000434	0.00439	CcSEcCtD
Aminoglutethimide—Myalgia—Triamcinolone—multiple sclerosis	0.000432	0.00437	CcSEcCtD
Aminoglutethimide—Vomiting—Azathioprine—multiple sclerosis	0.000432	0.00437	CcSEcCtD
Aminoglutethimide—Myalgia—Methylprednisolone—multiple sclerosis	0.000431	0.00436	CcSEcCtD
Aminoglutethimide—Drowsiness—Methotrexate—multiple sclerosis	0.000429	0.00434	CcSEcCtD
Aminoglutethimide—Rash—Azathioprine—multiple sclerosis	0.000428	0.00434	CcSEcCtD
Aminoglutethimide—Dermatitis—Azathioprine—multiple sclerosis	0.000428	0.00433	CcSEcCtD
Aminoglutethimide—Headache—Azathioprine—multiple sclerosis	0.000426	0.00431	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000423	0.00653	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000405	0.0041	CcSEcCtD
Aminoglutethimide—Tachycardia—Triamcinolone—multiple sclerosis	0.000404	0.00409	CcSEcCtD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000404	0.00624	CbGpPWpGaD
Aminoglutethimide—Nausea—Azathioprine—multiple sclerosis	0.000403	0.00408	CcSEcCtD
Aminoglutethimide—Tachycardia—Methylprednisolone—multiple sclerosis	0.000403	0.00408	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Methotrexate—multiple sclerosis	0.0004	0.00405	CcSEcCtD
Aminoglutethimide—Myalgia—Betamethasone—multiple sclerosis	0.000392	0.00397	CcSEcCtD
Aminoglutethimide—Myalgia—Dexamethasone—multiple sclerosis	0.000392	0.00397	CcSEcCtD
Aminoglutethimide—Hypotension—Methylprednisolone—multiple sclerosis	0.000386	0.00391	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000382	0.0059	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000382	0.0059	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000377	0.00382	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000377	0.00381	CcSEcCtD
Aminoglutethimide—Anaemia—Prednisone—multiple sclerosis	0.000371	0.00375	CcSEcCtD
Aminoglutethimide—Tachycardia—Betamethasone—multiple sclerosis	0.000367	0.00371	CcSEcCtD
Aminoglutethimide—Tachycardia—Dexamethasone—multiple sclerosis	0.000367	0.00371	CcSEcCtD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000364	0.00561	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000364	0.00561	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000359	0.00554	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000359	0.00554	CbGpPWpGaD
Aminoglutethimide—Anorexia—Dexamethasone—multiple sclerosis	0.000358	0.00363	CcSEcCtD
Aminoglutethimide—Anorexia—Betamethasone—multiple sclerosis	0.000358	0.00363	CcSEcCtD
Aminoglutethimide—Urticaria—Prednisolone—multiple sclerosis	0.000358	0.00362	CcSEcCtD
Aminoglutethimide—Hypotension—Betamethasone—multiple sclerosis	0.000351	0.00356	CcSEcCtD
Aminoglutethimide—Hypotension—Dexamethasone—multiple sclerosis	0.000351	0.00356	CcSEcCtD
Aminoglutethimide—Vomiting—Mitoxantrone—multiple sclerosis	0.000349	0.00353	CcSEcCtD
Aminoglutethimide—Rash—Mitoxantrone—multiple sclerosis	0.000346	0.0035	CcSEcCtD
Aminoglutethimide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000346	0.0035	CcSEcCtD
Aminoglutethimide—Headache—Mitoxantrone—multiple sclerosis	0.000344	0.00348	CcSEcCtD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000343	0.0053	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.000343	0.00529	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000342	0.00347	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000342	0.00347	CcSEcCtD
Aminoglutethimide—Myalgia—Prednisone—multiple sclerosis	0.000341	0.00346	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Prednisolone—multiple sclerosis	0.000332	0.00336	CcSEcCtD
Aminoglutethimide—Urticaria—Triamcinolone—multiple sclerosis	0.000329	0.00333	CcSEcCtD
Aminoglutethimide—Urticaria—Methylprednisolone—multiple sclerosis	0.000328	0.00332	CcSEcCtD
Aminoglutethimide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000327	0.00332	CcSEcCtD
Aminoglutethimide—Decreased appetite—Betamethasone—multiple sclerosis	0.000327	0.00331	CcSEcCtD
Aminoglutethimide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000327	0.00331	CcSEcCtD
Aminoglutethimide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000326	0.00504	CbGpPWpGaD
Aminoglutethimide—Nausea—Mitoxantrone—multiple sclerosis	0.000326	0.0033	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisone—multiple sclerosis	0.000319	0.00323	CcSEcCtD
Aminoglutethimide—Anorexia—Prednisone—multiple sclerosis	0.000312	0.00316	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000311	0.0048	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000311	0.0048	CbGpPWpGaD
Aminoglutethimide—Anaemia—Methotrexate—multiple sclerosis	0.00031	0.00314	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000305	0.00309	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000305	0.00308	CcSEcCtD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.000301	0.00464	CbGpPWpGaD
Aminoglutethimide—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.0003	0.00464	CbGpPWpGaD
Aminoglutethimide—Leukopenia—Methotrexate—multiple sclerosis	0.0003	0.00304	CcSEcCtD
Aminoglutethimide—Urticaria—Dexamethasone—multiple sclerosis	0.000299	0.00302	CcSEcCtD
Aminoglutethimide—Urticaria—Betamethasone—multiple sclerosis	0.000299	0.00302	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000298	0.00302	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisolone—multiple sclerosis	0.000298	0.00302	CcSEcCtD
Aminoglutethimide—Body temperature increased—Betamethasone—multiple sclerosis	0.000297	0.00301	CcSEcCtD
Aminoglutethimide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000297	0.00301	CcSEcCtD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000295	0.00455	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000295	0.00455	CbGpPWpGaD
Aminoglutethimide—Pruritus—Triamcinolone—multiple sclerosis	0.000293	0.00297	CcSEcCtD
Aminoglutethimide—Pruritus—Methylprednisolone—multiple sclerosis	0.000292	0.00296	CcSEcCtD
Aminoglutethimide—Myalgia—Methotrexate—multiple sclerosis	0.000285	0.00289	CcSEcCtD
Aminoglutethimide—Decreased appetite—Prednisone—multiple sclerosis	0.000285	0.00288	CcSEcCtD
Aminoglutethimide—Rash—Prednisolone—multiple sclerosis	0.000284	0.00288	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisolone—multiple sclerosis	0.000284	0.00287	CcSEcCtD
Aminoglutethimide—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000283	0.00437	CbGpPWpGaD
Aminoglutethimide—Headache—Prednisolone—multiple sclerosis	0.000282	0.00286	CcSEcCtD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00028	0.00433	CbGpPWpGaD
Aminoglutethimide—Dizziness—Triamcinolone—multiple sclerosis	0.000274	0.00277	CcSEcCtD
Aminoglutethimide—Dizziness—Methylprednisolone—multiple sclerosis	0.000273	0.00277	CcSEcCtD
Aminoglutethimide—Nausea—Prednisolone—multiple sclerosis	0.000268	0.00271	CcSEcCtD
Aminoglutethimide—Pruritus—Dexamethasone—multiple sclerosis	0.000266	0.00269	CcSEcCtD
Aminoglutethimide—Pruritus—Betamethasone—multiple sclerosis	0.000266	0.00269	CcSEcCtD
Aminoglutethimide—Vomiting—Triamcinolone—multiple sclerosis	0.000263	0.00267	CcSEcCtD
Aminoglutethimide—Vomiting—Methylprednisolone—multiple sclerosis	0.000263	0.00266	CcSEcCtD
Aminoglutethimide—Rash—Triamcinolone—multiple sclerosis	0.000261	0.00264	CcSEcCtD
Aminoglutethimide—Dermatitis—Triamcinolone—multiple sclerosis	0.000261	0.00264	CcSEcCtD
Aminoglutethimide—Anorexia—Methotrexate—multiple sclerosis	0.000261	0.00264	CcSEcCtD
Aminoglutethimide—Rash—Methylprednisolone—multiple sclerosis	0.000261	0.00264	CcSEcCtD
Aminoglutethimide—Dermatitis—Methylprednisolone—multiple sclerosis	0.00026	0.00264	CcSEcCtD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.00026	0.00402	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.00026	0.00402	CbGpPWpGaD
Aminoglutethimide—Urticaria—Prednisone—multiple sclerosis	0.00026	0.00263	CcSEcCtD
Aminoglutethimide—Headache—Triamcinolone—multiple sclerosis	0.00026	0.00263	CcSEcCtD
Aminoglutethimide—Headache—Methylprednisolone—multiple sclerosis	0.000259	0.00262	CcSEcCtD
Aminoglutethimide—Body temperature increased—Prednisone—multiple sclerosis	0.000259	0.00262	CcSEcCtD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000257	0.00396	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000257	0.00396	CbGpPWpGaD
Aminoglutethimide—Hypotension—Methotrexate—multiple sclerosis	0.000256	0.00259	CcSEcCtD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000254	0.00392	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000249	0.00252	CcSEcCtD
Aminoglutethimide—Dizziness—Dexamethasone—multiple sclerosis	0.000249	0.00252	CcSEcCtD
Aminoglutethimide—Dizziness—Betamethasone—multiple sclerosis	0.000249	0.00252	CcSEcCtD
Aminoglutethimide—Nausea—Triamcinolone—multiple sclerosis	0.000246	0.00249	CcSEcCtD
Aminoglutethimide—Nausea—Methylprednisolone—multiple sclerosis	0.000246	0.00249	CcSEcCtD
Aminoglutethimide—Somnolence—Methotrexate—multiple sclerosis	0.000243	0.00246	CcSEcCtD
Aminoglutethimide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000243	0.00375	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Prednisone—multiple sclerosis	0.000241	0.00244	CcSEcCtD
Aminoglutethimide—Vomiting—Dexamethasone—multiple sclerosis	0.000239	0.00242	CcSEcCtD
Aminoglutethimide—Vomiting—Betamethasone—multiple sclerosis	0.000239	0.00242	CcSEcCtD
Aminoglutethimide—Decreased appetite—Methotrexate—multiple sclerosis	0.000238	0.00241	CcSEcCtD
Aminoglutethimide—Rash—Betamethasone—multiple sclerosis	0.000237	0.0024	CcSEcCtD
Aminoglutethimide—Rash—Dexamethasone—multiple sclerosis	0.000237	0.0024	CcSEcCtD
Aminoglutethimide—Dermatitis—Dexamethasone—multiple sclerosis	0.000237	0.0024	CcSEcCtD
Aminoglutethimide—Dermatitis—Betamethasone—multiple sclerosis	0.000237	0.0024	CcSEcCtD
Aminoglutethimide—Headache—Betamethasone—multiple sclerosis	0.000235	0.00238	CcSEcCtD
Aminoglutethimide—Headache—Dexamethasone—multiple sclerosis	0.000235	0.00238	CcSEcCtD
Aminoglutethimide—Pruritus—Prednisone—multiple sclerosis	0.000232	0.00234	CcSEcCtD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000227	0.00351	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000224	0.00346	CbGpPWpGaD
Aminoglutethimide—Nausea—Dexamethasone—multiple sclerosis	0.000223	0.00226	CcSEcCtD
Aminoglutethimide—Nausea—Betamethasone—multiple sclerosis	0.000223	0.00226	CcSEcCtD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000222	0.00343	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000221	0.00341	CbGpPWpGaD
Aminoglutethimide—Urticaria—Methotrexate—multiple sclerosis	0.000217	0.0022	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisone—multiple sclerosis	0.000216	0.00219	CcSEcCtD
Aminoglutethimide—Body temperature increased—Methotrexate—multiple sclerosis	0.000216	0.00219	CcSEcCtD
Aminoglutethimide—Vomiting—Prednisone—multiple sclerosis	0.000208	0.00211	CcSEcCtD
Aminoglutethimide—Rash—Prednisone—multiple sclerosis	0.000206	0.00209	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisone—multiple sclerosis	0.000206	0.00209	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000206	0.00318	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000206	0.00318	CbGpPWpGaD
Aminoglutethimide—Headache—Prednisone—multiple sclerosis	0.000205	0.00208	CcSEcCtD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000203	0.00313	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000203	0.00313	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Methotrexate—multiple sclerosis	0.000202	0.00204	CcSEcCtD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.0002	0.00309	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.0002	0.00309	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—SRM—multiple sclerosis	0.000197	0.00304	CbGpPWpGaD
Aminoglutethimide—Nausea—Prednisone—multiple sclerosis	0.000194	0.00197	CcSEcCtD
Aminoglutethimide—Pruritus—Methotrexate—multiple sclerosis	0.000194	0.00196	CcSEcCtD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000187	0.00289	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—POMC—multiple sclerosis	0.000182	0.00281	CbGpPWpGaD
Aminoglutethimide—Dizziness—Methotrexate—multiple sclerosis	0.000181	0.00183	CcSEcCtD
Aminoglutethimide—Vomiting—Methotrexate—multiple sclerosis	0.000174	0.00176	CcSEcCtD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000173	0.00268	CbGpPWpGaD
Aminoglutethimide—Rash—Methotrexate—multiple sclerosis	0.000172	0.00175	CcSEcCtD
Aminoglutethimide—Dermatitis—Methotrexate—multiple sclerosis	0.000172	0.00174	CcSEcCtD
Aminoglutethimide—Headache—Methotrexate—multiple sclerosis	0.000171	0.00173	CcSEcCtD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.00017	0.00262	CbGpPWpGaD
Aminoglutethimide—Nausea—Methotrexate—multiple sclerosis	0.000163	0.00164	CcSEcCtD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000157	0.00242	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000157	0.00242	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000154	0.00238	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000154	0.00238	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP27B1—multiple sclerosis	0.000138	0.00214	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP24A1—multiple sclerosis	0.000138	0.00214	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000136	0.0021	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000135	0.00209	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—SRM—multiple sclerosis	0.00013	0.00201	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GPC5—multiple sclerosis	0.000127	0.00196	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Biological oxidations—POMC—multiple sclerosis	0.000121	0.00186	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00011	0.0017	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000109	0.00168	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000106	0.00164	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—RRM1—multiple sclerosis	0.000105	0.00162	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.0001	0.00154	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.0001	0.00154	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	9.73e-05	0.0015	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	9.69e-05	0.0015	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	9.17e-05	0.00142	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	9.17e-05	0.00142	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.97e-05	0.00138	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.59e-05	0.00133	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GPC5—multiple sclerosis	8.39e-05	0.0013	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.18e-05	0.00126	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.14e-05	0.00126	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.79e-05	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.79e-05	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	7.74e-05	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.58e-05	0.00117	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	7.57e-05	0.00117	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	7.56e-05	0.00117	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.41e-05	0.00114	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	7.06e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	7.06e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7e-05	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—RRM1—multiple sclerosis	6.95e-05	0.00107	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.63e-05	0.00102	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.38e-05	0.000985	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SRM—multiple sclerosis	6.32e-05	0.000976	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—BCHE—multiple sclerosis	6.03e-05	0.000931	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.86e-05	0.000904	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.39e-05	0.000833	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SRM—multiple sclerosis	4.92e-05	0.00076	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.63e-05	0.000716	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.56e-05	0.000705	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.45e-05	0.000687	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.45e-05	0.000687	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.35e-05	0.000672	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.22e-05	0.000652	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.07e-05	0.000629	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—BCHE—multiple sclerosis	3.99e-05	0.000617	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SRM—multiple sclerosis	3.8e-05	0.000587	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—APOE—multiple sclerosis	3.63e-05	0.00056	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.52e-05	0.000544	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.47e-05	0.000536	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.47e-05	0.000536	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.39e-05	0.000524	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.37e-05	0.000521	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.17e-05	0.00049	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—POMC—multiple sclerosis	3.12e-05	0.000481	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ALB—multiple sclerosis	2.84e-05	0.000439	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.68e-05	0.000413	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.68e-05	0.000413	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.63e-05	0.000406	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.62e-05	0.000404	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.45e-05	0.000378	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—APOE—multiple sclerosis	2.4e-05	0.000371	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.25e-05	0.000347	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—POMC—multiple sclerosis	2.06e-05	0.000319	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.05e-05	0.000317	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.04e-05	0.000315	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.03e-05	0.000313	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.94e-05	0.000299	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ALB—multiple sclerosis	1.88e-05	0.000291	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.75e-05	0.000271	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.6e-05	0.000247	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.000233	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—APOE—multiple sclerosis	1.17e-05	0.00018	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.00018	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—POMC—multiple sclerosis	1e-05	0.000155	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ALB—multiple sclerosis	9.13e-06	0.000141	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—APOE—multiple sclerosis	9.08e-06	0.00014	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—POMC—multiple sclerosis	7.8e-06	0.00012	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ALB—multiple sclerosis	7.11e-06	0.00011	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—APOE—multiple sclerosis	7.01e-06	0.000108	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—POMC—multiple sclerosis	6.02e-06	9.3e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ALB—multiple sclerosis	5.49e-06	8.48e-05	CbGpPWpGaD
